Introduction {#S1}
============

The worldwide popularity of football results in competitive matches being held in a whole host of environmental conditions, some of which can be in excess of 30°C with high levels of RH ([@B42]). The 2016 Olympic Games in Brazil and the future 2020 Olympics in Tokyo, Japan ([@B23]) are examples of this.

It has been reported that the menstrual cycle plays a significant role in athletic performance in the heat ([@B7]; [@B56]; [@B29]). However, research is limited and recent evidence has been contradictory. It has demonstrated little effect of the menstrual cycle ([@B54]), oral contraceptive pill (OCP) usage ([@B37]) and in trained females who have smaller fluctuations in hormonal response ([@B36]). However, the possible attenuation of endurance performance during heat stress has been reported ([@B7]; [@B56]; [@B13]; [@B29]) but this is not a universal finding ([@B34]; [@B54]; [@B37]). Secondly, there is limited research on fluid handling across the menstrual cycle with OCP usage ([@B51]; [@B49]). This supports the need for a robust research design in the present study. It is recognized that resting core temperature and the temperature threshold for the activation of the thermoregulatory responses, cutaneous vasodilation and sweating in females is elevated during the luteal phase of the menstrual cycle ([@B50]; [@B54]). Especially, in those taking the OCP ([@B11]; [@B45]) which can rise by ∼0.2--0.6°C in the early follicular phase ([@B52]; [@B33]; [@B26]; [@B45]). Many women feel that the menstrual cycle status negatively affects athletic performance ([@B62]; [@B10]) but in reality it has been reported that most physical aspects of athletic performance are not hindered by the menstrual cycle ([@B35]; [@B13]; [@B60]; [@B57]). In summary, research on how the menstrual cycle phase affects exercise performance in unacclimated females in the heat is limited and contradictory. Furthermore, the limited information on female sex hormones, OCP and fluid regulation by Stachenfeld and colleagues ([@B51]; [@B49]) supports the research design of the present study.

There are fundamentally three models in which active heat acclimation can be achieved; (i) constant work-rate, (ii) self-regulated exercise and (iii) the controlled hyperthermia or isothermic technique ([@B55]). The controlled hyperthermia technique has been postulated to provide greater heat adaptation than the constant work-rate and self-regulated work-rate methodologies. On the basis that core temperature elevation is a key consideration for successful heat acclimation associated with high skin temperature and sweating response, as exercise alone is not a sufficient stimulus for adaptation ([@B27]). In contrast, there has been evidence to demonstrate isothermic and fixed intensity heat acclimation methods induce similar heat adaptation in the short and long-term. However, it is suggested controlled-hyperthermia is a more efficient and practical method for heat adaptation, especially for athletes tapering before competition ([@B24]). The addition of a permissive dehydration stimulus, that is restricting fluid intake during acclimation has received recent attention in the literature ([@B1]) and with a female cohort ([@B32]). However, the benefits of permissive dehydration has not been reported universally ([@B40]). In our previous work using a male cohort ([@B21]), permissive dehydration during acclimation has been shown to improve the fluid regulatory mechanisms by improving the reabsorption of water and *Na*^+^ resulting in PV expansion. This indicated that the adaptive response may be enhanced rather than impaired by dehydration acclimation and this work had a euhydration control. Furthermore, we have demonstrated that the use of permissive dehydration with STHA (5-days) has been shown to provide heat adaptation for moderately ([@B20]) and highly trained ([@B19]) male athletes. From a practical perspective it provides a very light exercise load that minimizes both additional exercise strain and the disruption of quality training during the tapering period for competition ([@B22]).

Most heat acclimation protocols have been carried out using male cohorts. Furthermore, the limited research that has been conducted using female participants, to the author's knowledge only three have used the controlled hyperthermia technique. [@B38] reported that in response to STHA of 5-days with permissive dehydration, there was limited physiological change. Improvements in cardiovascular stability, lower core temperature and sudomotor adaptation required a longer, medium-term heat acclimation (MTHA) of 10-days ([@B38]). Similarly, [@B32] determined nine-, but not 4-days heat acclimation with permissive dehydration, improves self-paced endurance performance in females ([@B32]). [@B14] demonstrated limited responses to STHA of 3-days in a younger versus an older female population ([@B14]). However, these studies may not give us all the information we need given their research designs have mixed OCP and non-users. Furthermore, they have not controlled for menstrual cycle phase.

The aims of the present study are to evaluate the physiological and performance effects of a STHA (5-day) protocol, using the controlled hyperthermia technique with no fluid intake, on an intermittent HST with a female cohort and controlling for menstrual cycle phase. It is hypothesized that STHA will improve thermoregulation in a cohort of young, moderately trained female game players when controlling for menstrual cycle phase.

Materials and Methods {#S2}
=====================

Experimental Design and Overview {#S2.SS1}
--------------------------------

Ten moderately trained female participants undertook a 5-day STHA regime, with no fluid replenishment during each daily acclimation session. Participants' thermoregulatory, cardiovascular and fluid-regulatory status were measured at rest and in response to an intermittent, exercising HST, administered the week before and after the 2nd day after the STHA regime to ensure 1 day of rest. Participants were asked to refrain from strenuous exercise immediately before and 24 h prior to each HST, as it has been demonstrated that lower resting core temperature contributes to reduced physiological strain during acclimation ([@B31]). A general overview of the STHA protocol for the moderately trained females is shown in [Figure 1](#F1){ref-type="fig"}.

![Schematic model of the short-term heat acclimation (STHA) protocol for moderately trained females.](fphys-10-01458-g001){#F1}

Participants {#S2.SS2}
------------

Ten, moderately trained, females (Mean \[SD\]; age 22.6 \[2.7\] years; stature 165.3 \[6.2\] cm; body mass 61.5 \[8.7\] kg; cardiac output 5.5 \[1.3\] L; and $\overset{.}{\text{V}}\text{O}_{2{peak}}$ 43.9 \[8.6\] mL⋅kg^--1^⋅min^--1^) participated. They were games players and oral contraceptive pill users (combined). Participants completed pre-exercise medical questionnaires and informed consent to participate in the study. All participants were in good health. The study had ethical approval (No. 1516177) from the University of Hull ethics committee following the World Health Organization declaration of Helsinki guidelines.

Protocol {#S2.SS3}
--------

### Experimental Standardization {#S2.SS3.SSS1}

All participants were fully informed of all experimental procedures (orally and written). Prior to experimental testing participants completed pre-exercise medical questionnaires and informed consents. Each female participant used a monophasic, oral contraceptive pill (OCP) and dose of hormone concentration differed between individuals depending on their specific medication. All participants were previously unacclimated to the heat and this study was completed outside the British summertime to minimize seasonal acclimatization effects. To minimize circadian rhythm affects HSTs and acclimations occurred at the same time of day. Participants were asked to refrain from strenuous exercise for 24 h prior to HSTs and using a food diary follow a consistent food intake. They were asked to refrain from caffeine and alcohol consumption 12 h before all testing procedures.

As a methodological control participants completed HST2 and HST3 in the same phase of their menstrual cycle (luteal phase), in the active pill portion of the OCP. This was reported by menstrual cycle questionnaire. This detailed the start of the menstrual cycle, premenstrual symptoms and contraceptive medication. This was confirmed by baseline measurement of plasma 17β-estradiol ([Table 1](#T1){ref-type="table"}).

###### 

Mean ± SD plasma 17β-estradiol in HST2 (pre-) and HST3 (post-) STHA in the luteal phases of the menstrual cycle.

  ----------------------------------- ------------- ------------
  Menstrual cycle week (*n* = 8)      3             3
  Heat stress test                    HST2          HST3
  Plasma 17β-estradiol (pg⋅mL^--1^)   29.7 ± 16.4   28.7 ± 8.0
  ----------------------------------- ------------- ------------

### Short-Term Heat Acclimation (STHA) {#S2.SS3.SSS2}

The STHA protocol consisted of five consecutive day's heat exposure (39.5°C; 60% RH) for 90 min a day, using the controlled hyperthermia technique ([@B20]), with permissive dehydration ([@B21]). Participants cycled (Monark 824E, Monark Exercise AB, Varberg, Sweden) against a self-selected resistance at 60 rpm attaining a *T*~*re*~ 38.5°C, as quickly as possible and maintained for the 90 min of exposure by regular adjustment of workload. However, an initial workload of 60 watts for the first 5 min duration was the same for all participants at the start of each day's trial. Elevation of *T*~*re*~ to the same point during heat exposures was to increase workload progressively during the week. The fluid-regulatory hormone aldosterone \[aldosterone\]~p~, electrolytes (*Na*^+^, *K*^+^, and *Cl*^−^), proteins (total protein \[TP\]~p~; Albumin \[alb\]~p~), cortisol \[cortisol\]~p~ and percentage change in plasma volume (%PV) were measured at rest and end of acclimation bouts on day 1 and day 5. Time (minutes) time to a *T*~*re*~ of 38.5°C and work (J) was recorded on each day of acclimation.

#### Urinary measures {#S2.SS3.SSS2.Px1}

Urine samples were obtained before and after day 1 and day 5 acclimation. Using fresh urine samples, urine specific gravity and urine color were measured using a calibrated refractometer (Uricon-N, Urine specific gravity refractometer, Atago Co., Tokyo, Japan) and urine color chart ([@B5], [@B4]), respectively. Urine volume was recorded and urine osmolality was analyzed after the experiment.

#### Blood measures {#S2.SS3.SSS2.Px2}

Plasma for the measurement of the fluid regulatory hormone aldosterone (200 μl) was stored using chilled K-EDTA tubes (1.6 mg⋅ml^--1^). Measurement of aldosterone and cortisol used the Coat-A Count aldosterone procedure. The intra-assay coefficient of variation for aldosterone and cortisol was 8.8 and 12.1%, respectively, for duplicate measures. All samples for a given individual were analyzed within the same assay. Plasma *Na*^+^, *K*^+^, and *Cl*^−^ was analyzed using duplicate colorometric analysis (Cobas Mira Plus, New Jersey, United States).

Changes in the concentration of hemoglobin \[Hb\] and haematocrit \[Hct\] were used to determine the relative change in plasma volume described by [@B15]. Venous blood samples (5 mL) were taken from an antecubital vein (Vacutainer Precision Glide 21-gauge needle, Becton Dickinson Vacutainer Systems) by phlebotomy without stasis and immediately analyzed -- in sexplicate -- for \[Hb\] ([@B61]), (Model OSM3, Radiometer, Copenhagen, Denmark), and \[Hct\] (using a Hawksley Microhematocrit centrifuge \[Sussex, United Kingdom\] and a Micro-capillary reader \[Damon/IEC Division, Mass, United States\]). The percentage change in plasma volume was analyzed from day 1 to 5 of the acclimation regime, during HSTs and calculated using a mathematical equation ([@B15]).

### Aerobic Fitness Testing and Cardiac Output {#S2.SS3.SSS3}

Participants performed an incremental ramp exercise test to volitional exhaustion on a treadmill (h/p/Cosmos, Model Pulsar 3p, Traunstein, Germany), for determination of peak oxygen uptake ($\overset{.}{\text{V}}\text{O}_{2{peak}}$) and velocities for individualisation of the HSTs. This procedure involved a starting velocity of 5 km/hr with workload increments of 0.1 km/hr every 6 s (1 km/hr/min), until volitional exhaustion. Breath by breath expired air was collected via a metabolic cart system (Cortex Metalyzer 3B, Cortex Biophysic, Leipzig, Germany). Participants RPE ([@B8]) and *f*~*c*~ (Polar FS1, Polar Electro, OY, Finland) were recorded every minute. All participants were given verbal encouragement in the latter stages of the incremental test.

Baseline cardiac output was measured using a breath-by-breath cardiac output analyser (Innocor, Innovision, Odense, Denmark). Prior to measurement, calibration of the cardiac output analyser was completed. Each participant had a fresh mouthpiece connected to a bacterial filter (Innovision, Odense, Denmark). A nose clip (Innovision, Odense, Denmark) was then placed over the participant's nose to prevent any expired air escaping. Participants were instructed to breathe in synchronization (∼5 breaths, ∼15 s) with the on-screen demonstration until measurement was complete.

### Heat Stress Test (HST) {#S2.SS3.SSS4}

The HST took place in an environmental chamber (Type SSR 60-20H, Design Environment, Gwent, United Kingdom) set to ambient temperature of 31°C; 50% RH. Pre-exercise urine and blood measure (%PV) were taken prior to entering the chamber. The HST consisted of 9 × 5 min blocks of intermittent exercise on a treadmill (Pulsar 3p, h/p/Cosmos, Traunstein, Germany) and cycle ergometer (Wattbike Ltd., Nottingham, United Kingdom). Each 5-min block consisted of intermittent treadmill running; standing (recovery), walking (50% HRmax), jogging (60% HRmax), low- (70% HRmax), moderate- (85% HRmax) and high-intensity (95% HRmax), ending with a 6-s maximal cycle ergometer sprint. Treadmill velocity changed every 5--11 s and percentage time spent at each velocity was adapted from collegiate level football match play characteristics ([@B58]). Sprint characteristics; peak power output (PPO) and mean power output (MPO) were used as performance measures.

Prior to acclimation, as a control trial, two HST's (HST1 vs. HST2) were performed and separated by 1 week. The post acclimation HST3 was performed within a week (5 ± 2 days) of the final acclimation day to prevent the decay of acclimation ([@B20]) and we acknowledge there may be some variability in the magnitude of response ([@B59]). To control for menstrual cycle phase the HST2 (Pre-) and HST3 (Post-) STHA trials were performed in week three of the menstrual cycle (luteal phase), in the active pill portion of the OCP for all participants. Baseline measures of plasma 17β-estradiol were taken prior to HST2 and HST3 trials in the luteal phase of the menstrual cycle and there was no difference (*P* = 0.87) observed ([Table 1](#T1){ref-type="table"}).

#### Body temperature {#S2.SS3.SSS4.Px1}

Core body temperature was measured using a rectal thermistor (U thermistor, Grant Instruments Ltd., Cambridge, United Kingdom) was self-inserted to a depth of 10 cm beyond the anal sphincter. Skin temperature was measured using skin thermistors (Type EUS-U-V5-V2, Grant Instruments Ltd., Cambridge, United Kingdom) placed on four, left sided, sites: chest, bicep, thigh, and calf, secured using micropore tape. Mean skin temperature (${\overline{T}}_{sk}$) ([@B44]) and mean body temperature (${\overline{T}}_{b}$) ([@B46]) were measured. Temperature data was recorded at 1-min intervals on a portable data logger (2020 series data logger, Grant Instruments Ltd., Cambridge, United Kingdom).

#### Data analysis {#S2.SS3.SSS4.Px2}

Sample size was based upon results from the previous limited research on females ([@B38]; [@B32]), using our permissive dehydration protocol during STHA ([@B21]). Where a statistical difference was observed in primary outcomes. The stress response of dependent measures in STHA and HSTs were analyzed for normal distribution by using the Shapiro--Wilk and the Brown--Forsythe test determined equal variance. All data were normally distributed and two-way repeated measures ANOVA was used to determine main effects between day 1 and 5 acclimation, pre vs post HSTs and interaction over time for all dependent measures. Pairwise multiple comparison procedures were analyzed using post-hoc Bonferroni correction *t*-tests when appropriate. The change in thermal markers on day 1 and day 5 of acclimation were analyzed using paired *t*-test analysis. Work output from day 1 to day 5 of acclimation was analyzed using one-way analysis of variance ANOVA, with repeated measures and Bonferroni correction *t*-tests to isolate differences between days. Data is reported for ten moderately trained females unless otherwise stated. Where appropriate data is reported as mean differences ± SD with 95% confidence intervals (95% CI) and the magnitude of effect using Cohen's *d* effect sizes (where 0.2--0.59 small; 0.6--1.19 moderate; 1.2--1.99 large; 2.0--4.0 very large).

Results {#S3}
=======

All ten participants completed the 5-day STHA protocol and three HSTs (HST1; HST2; HST3). The HST1 versus HST2 was a control trial taken 1 week apart with no intervention. The HST2 versus HST3 with the STHA intervention took place in week 3 of the menstrual cycle (luteal phase) for all ten participants. Due to issues with venepuncture measures blood parameters were analyzed for eight participants only. Similarly, eight participants had baseline plasma 17β-estradiol measured before HST2 and HST3 trials in the luteal phase.

Acclimation {#S3.SS1}
-----------

### Thermal Stress and Strain {#S3.SS1.SSS1}

Thermal stress and strain from days 1 to 5 of heat acclimation are presented in [Table 2](#T2){ref-type="table"} and work completed in [Figure 2](#F2){ref-type="fig"}.

###### 

Thermal stress and strain on the first (Day 1) and last day (Day 5) of short-term heat acclimation (STHA) for ten moderately trained females.

                                   **Day 1**      **Day 5**       ***P*-value**
  -------------------------------- -------------- --------------- ---------------
  *T*~*a*~ (°C)                    39.6 ± 0.1     39.7 ± 0.2      0.14
  RH (%)                           60.0 ± 0.2     60.1 ± 0.1      0.72
  Mean *f*~*c*~ (b⋅min^--1^)       144 ± 22       141 ± 19        0.11
  Mean *T*~*re*~ (°C)              38.29 ± 0.46   38.24 ± 0.47    0.24
  Time to *T*~*re*~ 38.5°C (min)   36.70 ± 6.36   44.62 ± 11.04   **0.04**
  Work (KJ)                        18.98 ± 5.94   23.03 ± 5.14    **0.02**
  Body mass change (%)             −1.7 ± 0.6     −1.8 ± 0.7      0.80
  %PV change                       0.9 ± 13.1     0.7 ± 12.0      0.98
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![Work output on the first day (Day 1) to the last day (Day 5) of acclimation after 90-min heat exposure. Data are mean ±SD are for ten moderately trained females. Significant difference ^∗^*p* \< 0.05; Day 1 to the last day of acclimation analyzed using one-way analysis of variance (ANOVA) with repeated measures and Bonferroni correction *t*-tests to isolate differences between days.](fphys-10-01458-g002){#F2}

Measures of ambient temperature (*T*~*a*~) and RH indicated that the thermal stress was similar on day 1 and 5 of acclimation. Similarly, the thermal strain was consistent between days illustrated by mean cardiac frequency (*f*~*c*~) and rectal temperature (*T*~*re*~) responses. Time to 38.5°C was longer on day 5 cf. day 1 ([Table 2](#T2){ref-type="table"}; *P* = 0.04). Therefore, less work was performed on day 1 cf. day 5 ([Table 2](#T2){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}; *P* = 0.02).

### Urinary Measures {#S3.SS1.SSS2}

To determine hydration status urine color (color~u~), urine osmolality (osm~u~), urine specific gravity (SG~u~) and body mass were measured at rest and 90 min, on day 1 and 5 of acclimation ([Table 3](#T3){ref-type="table"}). There was no main effect (*P* \> 0.05) and interaction across time (*P* \> 0.05) for color~u~, osm~u~, SG~u~ and body mass on day 1 and 5 of STHA.

###### 

Urinary measures of hydration (color~u~, osm~u~, SG~u~) and nude body mass, at rest and end-exercise, on day 1 and 5 of short-term heat acclimation.

                     **Day 1:rest**   **Day 1:end**   **Day 5:rest**   **Day 5:end**
  ------------------ ---------------- --------------- ---------------- ---------------
  Color~u~ (units)   2 ± 1            4 ± 2           3 ± 1            4 ± 2
  osm~u~ (mOsm/kg)   379 ± 292        447 ± 181       379 ± 267        396 ± 271
  SG~u~ (units)      1.008 ± 0.007    1.012 ± 0.007   1.008 ± 0.006    1.010 ± 0.008
  Body mass (kg)     62.3 ± 9.9       61.2 ± 9.8      62.5 ± 9.8       61.4 ± 9.7

Data presented as mean ±SD for ten female participants. A two-way repeated measures ANOVA and post-hoc Bonferroni correction

t

-tests when appropriate was used to determine the differences from rest to end-heat exposure, on day 1 and 5 of short-term heat acclimation.

### Blood Measurements {#S3.SS1.SSS3}

Blood measures and percentage change on the first day (Day 1) to the last day (Day 5) of acclimation after 90-min heat exposure are presented in [Table 4](#T4){ref-type="table"}.

###### 

Blood measures and percentage change from rest to end-exposure on the first day (Day 1) versus the last day (Day 5) of acclimation after 90-min heat exposure.

                    **\[aldo\]~p~**   **\[Na^+^\]~p~**   **\[TP\]~p~**   **\[alb\]~p~**   **\[cortisol\]~p~**
  ----------------- ----------------- ------------------ --------------- ---------------- ---------------------
  **Day 1**                                                                               
  **Acclimation**                                                                         
   Rest             216 ± 131         140 ± 2            72.8 ± 3.2      670 ± 36         172 ± 63
   End              417 ± 99          141 ± 1            78.3 ± 3.0      716 ± 33         307 ± 47^∗^
   %Change          48%               1%                 7%              6%               44%
  **Day 5**                                                                               
  **Acclimation**                                                                         
   Rest             187 ± 64          139 ± 1            71.6 ± 4.8      666 ± 41         190 ± 47
   End              332 ± 143         142 ± 2            77.6 ± 5.7      717 ± 52         200 ± 67
   %Change          44%               2%                 8%              7%               5%

Data are mean ±SD for eight moderately trained females. A two-way repeated measures ANOVA and post-hoc Bonferroni correction

t

-tests when appropriate was used to determine the differences from rest to end-heat exposure, on day 1 and 5 of short-term heat acclimation.

∗

P

\< 0.05 at rest versus end-heat exposure (90 min) on day 1 and 5.

There was no main effect for \[aldo\]~p~ between day 1 and 5 (*F* = 1.583; *P* = 0.25) or interaction across time (*F* = 0.755; *P* = 0.41). Similarly, there was no main effect between day 1 and 5 for \[Na^+^\]~p~ (*F* = 1.106; *P* = 0.32) or interaction across time (*F* = 0.983; *P* = 0.36). The measure \[TP\]~p~ demonstrated no main effect between day 1 and 5 (*F* = 0.93; *P* = 0.37) or interaction across time (*F* = 0.198; *P* = 0.67). There was no main effect between day 1 and 5 (*F* = 0.0618; *P* = 0.81) for \[alb\]~p~ or interaction across time (*F* = 0.50; *P* = 0.50). In contrast, there was a significant main effect between day 1 and 5 for \[cortisol\]~p~ (*F* = 15.303; *P* = 0.01), and interaction across time (*F* = 10.775; *P* = 0.02). Bonferroni-corrected post-hoc comparisons showed a significant difference between pre and post measures within day 1 (*P* = 0.002) but not on day 5 (*P* = 0.57).

### Heat Stress Test {#S3.SS1.SSS4}

Measurements were taken at rest and across the 45 min in HSTs. Data is presented for ten female participants unless otherwise stated.

### Control Study {#S3.SS1.SSS5}

The HST1 versus HST2 was a control trial taken 1 week apart with no intervention. There was a limited change for *T*~*re*~, ${\overline{T}}_{sk}$, ${\overline{T}}_{b}$, *f*~*c*~, and %PV (*P* \> 0.05). Similarly, in the sprint performance test the PPO and MPO demonstrated limited change (*P* \> 0.05).

### Intervention Study {#S3.SS1.SSS6}

The HST2 trial took place 1 week before the STHA (5-days), with no fluid intake intervention. The post HST3 occurred within 7-days of the last acclimation.

#### Body temperatures {#S3.SS1.SSS6.Px1}

[Figure 3](#F3){ref-type="fig"} presents mean ± SD rectal temperature (*T*~*re*~), mean skin temperature (${\overline{T}}_{sk}$) and mean body temperature (${\overline{T}}_{b}$), pre- to post acclimation in hot conditions (31°C; 50% RH; *n* = 10).

![Mean ± SD rectal temperature (*T*~*re*~) (upper plate), mean skin temperature (${\overline{T}}_{sk}$) (mid plate) and mean body temperature (${\overline{T}}_{b}$) (lower plate), pre- to post acclimation in hot conditions (31°C; 50% RH; *n* = 10). ^∗^*P* \< 0.05 post-hoc Bonferroni correction *t*-tests.](fphys-10-01458-g003){#F3}

There was no main effect for *T*~*re*~(*F* = 1.411; *P* = 0.27) after STHA but there was a significant interaction across time (*F* = 2.991; *P* = 0.004). Bonferroni-corrected post-hoc comparisons showed a significant mean difference at 40 (*P* = 0.01) and 45 min (*P* = 0.007). At 45 min *T*~*re*~ reduced by 0.20°C (95%CI −0.30 to −0.10°C; *d* = 0.77: Moderate). There was a significant main effect for ${\overline{T}}_{sk}$ (*F* = 5.252; *P* = 0.05) after STHA and interaction across time (*F* = 4.689; *P* = 0.001). Bonferroni-corrected post-hoc comparisons showed a significant mean difference at 15 (*P* = 0.043), 30 (*P* = 0.03); 35 (*P* = 0.004); 40 (*P* = 0.009) and 45 min (*P* = 0.009). The reduction in ${\overline{T}}_{sk}$ at 45 min was −0.50 (−0.90 to −0.10°C; *d* = 0.80: Moderate). There was no main effect for ${\overline{T}}_{b}$ (*F* = 4.419; *P* = 0.07) after STHA but there was a significant interaction across time (*F* = 3.942; *P* = 0.001). Bonferroni-corrected post-hoc comparisons showed a significant mean difference at 35 (*P* = 0.01), 40 (*P* = 0.002) and 45 min (*P* = 0.001). At 45 min ${\overline{T}}_{b}$ reduced by −0.25 (−0.35 to −0.15°C; *d* = 0.92: Moderate).

#### Cardiac frequency and percentage change in plasma volume (%PV) {#S3.SS1.SSS6.Px2}

There was a significant main effect for cardiac frequency (*F* = 7.702; *P* = 0.02) after STHA and interaction across time (*F* = 2.485; *P* = 0.02). Bonferroni-corrected post-hoc comparisons showed a significant mean difference at rest (*P* = 0.001), 5 (*P* = 0.04) and 45 min (*P* = 0.003). Cardiac frequency reduced at rest (−13; −18 to −7 b⋅min^--1^; *d* = 1.04: Moderate) and at 45-min (−8; −16 to −1 b⋅min^--1^; *d* = 1.11: Moderate). There was an increase in %PV from baseline post STHA by 7.0% (−0.4 to 14.5%, *d* = 1.27: Large).

#### Psychophysiological {#S3.SS1.SSS6.Px3}

There was a significant main effect for thermal comfort (*F* = 27.156; *P* = 0.001) after STHA and interaction across time (*F* = 3.378; *P* = 0.001). Bonferroni-corrected post-hoc comparisons showed a significant mean difference from 10 to 45 min (*P* \< 0.05). Thermal comfort reduced at 45 min by −1 (−1.5 to −0.5 units; *d* = 0.89: Moderate). There was a significant main effect for thermal sensation (*F* = 19.462; *P* = 0.002) after STHA and interaction across time (*F* = 4.533; *P* = 0.001). Bonferroni-corrected post-hoc comparisons showed a significant mean difference at 0 to 10 and 20 to 45 min (*P* \< 0.05). Thermal sensation reduced at 45 min by −1 (−1.5 to −0.0 units; *d* = 0.67: Moderate). There was a significant main effect for RPE (*F* = 5.831; *P* = 0.04) after STHA and interaction effect across time (*F* = 2.853; *P* = 0.006). Bonferroni-corrected post-hoc comparisons showed a significant mean difference 20 (*P* = 0.04), 25 (*P* = 0.04) 30 (*P* = 0.02), 40 (*P* = 0.01) and 45 min (*P* = 0.01). RPE decreased at 45 min by −2 (−4 to 0 units; *d* = 0.70: Moderate).

#### Repeated sprint performance {#S3.SS1.SSS6.Px4}

The PPO and MPO were measured across all nine, 6-s maximal sprints in the 45-min protocol ([Figure 4](#F4){ref-type="fig"}).

![Mean ± SD of mean power output (MPO) in maximal sprint performance, pre- to post acclimation in hot conditions (31°C; 50% RH; *n* = 9).](fphys-10-01458-g004){#F4}

There was no main effect for PPO (*F* = 1.458; *P* = 0.26) after STHA or significant interaction effect across all nine sprints (*F* = 0.397; *P* = 0.91). There was not a main effect for MPO (*F* = 3.064; *P* = 0.12) after STHA but the interaction across all nine sprints was close to significance (*F* = 0.296; *P* = 0.06). The MPO increased across all nine maximal sprints by 56W (−26 to 139W; *d* = 0.69: Moderate; *n* = 9).

Discussion {#S4}
==========

Effectiveness of Short-Term Heat Acclimation {#S4.SS1}
--------------------------------------------

The adaptations from short-term (5-d) heat acclimation with no fluid intake during acclimation, using the controlled hyperthermia technique, reduced exercising cardiovascular strain in females controlling for menstrual cycle phase. The cardiovascular stability was due to increased heat loss rather than lower heat content (∼resting core temperature), at the time of day of testing HSTs. This concurs with our previous work that has used no fluid intake during acclimation but with moderately ([@B20]) and highly trained males ([@B19]). However, it is in contrast with the limited work on STHA with females, using controlled-hyperthermia with permissive dehydration ([@B38]; [@B32]).

Adaptation to Exercise in the Heat and Menstrual Cycle Phase {#S4.SS2}
------------------------------------------------------------

The post acclimation HST3 was performed within a week of the final acclimation day to prevent the decay of acclimation ([@B20]). It has long been recognized that the menstrual cycle plays a significant role in athletic performance ([@B7]; [@B56]; [@B29]). Therefore, to control for menstrual cycle phase the HST2 (Pre-) and HST3 (Post-) STHA trials were performed in week 3 of menstrual cycle (luteal phase), with all participants using oral contraceptive pills (combined). This was determined by menstrual cycle questionnaire and baseline measures of plasma 17β-estradiol. This was measured prior to HST2 and HST3 intervention trials and there was no statistical difference observed ([Table 1](#T1){ref-type="table"}). It has previously been reported that heat adaptation in females is not affected by menstrual cycle phase ([@B37]; [@B36]) or the use of oral contraceptive pill ([@B6]). However, menstrual cycle phase and the associated changes in female sex hormones can influence core temperature ([@B28]), the overall thermoregulatory set point range ([@B12]) but a limited effect on whole body heat loss has been reported ([@B41]).

The present results using a female cohort and controlling for menstrual cycle phase, undergoing STHA of daily controlled hyperthermia with no fluid intake, demonstrated that the participants experienced adaptation to the heat. This was indicated by the characteristic features of acclimation. A decrease in *T*~*re*~ by −0.2°C ([Figure 3](#F3){ref-type="fig"}; top panel), ${\overline{T}}_{sk}$ by −0.5°C ([Figure 3](#F3){ref-type="fig"}; mid panel) and ${\overline{T}}_{b}$ by −0.25 ([Figure 3](#F3){ref-type="fig"}; lower panel) was observed. Similar body temperature measures have previously been reported by the author, using the hyperthermia-control technique but with male participants ([@B20], [@B19], [@B21]). In contrast, the research group of [@B38] reported that the employment of the controlled hyperthermia model with permissive dehydration successfully attenuated *T*~*re*~ during a 30-min run in the heat after 5 days in males (−0.39 ± 0.36°C) but not in females (−0.07 ± 0.18°C). Yet after a further 5 days of acclimation the females *T*~*re*~ response was similar by 0.48 ± 0.27°C ([@B38]). This indicates that a female population requires a longer-term intervention than the 5-days STHA we employed ([@B38]). Similarly, [@B32] determined nine-, but not 4-days heat acclimation improves self-paced endurance performance in females, using hyperthermia control with permissive dehydration ([@B32]). However, this was over a shorter 4-day STHA. Furthermore, in these two studies there were method differences with the present work. The exercise protocols were short in duration (∼30 min), self-paced/fixed speed trials and importantly menstrual OCP phase was not controlled.

End-exercise  *f*~*c*~ decreased by 8 b⋅min^--1^. Increased cardiovascular stability is recognized as one of the most rapidly occurring adaptations to the heat ([@B20], [@B22]). Furthermore, a 7.0% PV expansion from baseline was observed in this study. Previous research suggests intravascular fluid expansion resulting from such increases in colloid-osmotic pressure ([@B48]; [@B47]) explains a majority of PV expansion ([@B25]). Therefore, this suggests that the PV expansion may have contributed to the greater cardiovascular stability that was observed. This is similar to the findings of [@B43] who demonstrated induced plasma volume expansion in a female cohort following 5-days high-intensity heat acclimation ([@B43]).

Repeated Sprint Performance {#S4.SS3}
---------------------------

This study demonstrated that an increase in MPO was close to significance across all nine maximal sprints after STHA of 5-days ([Figure 4](#F4){ref-type="fig"}). This improvement in intermittent performance is supported by [@B53] who developed a heat acclimation protocol (4-days) for female team sports ([@B53]). They reported a reduced rate of rise in rectal temperature and a 33% improvement in distance run during a repeated shuttle run performance test after STHA in a female cohort. From a practical perspective, an improvement in sprint performance is a valuable asset in team sport situations. Work-rate during team sports matches are largely determined by the oppositions playing style of the opposing team and individuals ([@B42]), the ability to maintain repeated sprint performance can determine when a games player gets to the ball first and outrun the opposition.

Fluid Regulation Response to Repeated Heat Stress {#S4.SS4}
-------------------------------------------------

In the present study, participants experienced the same thermal load and this is the basis of using the controlled hyperthermia technique for heat acclimation. Individual's experienced a mild hypohydration of ∼2% body mass ([Table 2](#T2){ref-type="table"}). This is similar to the imposed hypohydration administered by Judelson and colleagues, who reported a modification in the hormonal and metabolic response to resistance exercise, influencing the post-exercise circulatory milieu ([@B30]). The research design of this study is supported by recommendations from earlier work with females on sex hormones and fluid regulation by the Stachenfeld research group ([@B51]; [@B49]).

Fluid Regulatory Hormones, Electrolytes and Plasma Volume Expansion {#S4.SS5}
-------------------------------------------------------------------

In the present study, after 90-min exercise \[aldo\]~p~ did not significantly increase across acclimation bouts ([Table 4](#T4){ref-type="table"}) and this is in contrast to what has previously been reported ([@B30]). The principal effects of aldosterone are the retention of *Na*^+^ and therefore water from the urine output to maintain extracellular fluid volume and thus blood volume. However, in the present study, an exercise-induced response of increased \[*Na*^+^\]~p~ was not clearly evident after the no fluid intake acclimation regime ([Table 4](#T4){ref-type="table"}). Therefore, this is in contrast with previous findings ([@B9]; [@B17]; [@B2]) who reported a strong relationship between increased *Na*^+^ with \[aldo\]~p~ response. In the present study, using the ΔPV ([@B15]) technique, there was an acclimation induced increase in resting %PV across HSTs by 7.0 ± 6% in the present study. This is similar to [@B43] who successfully induced plasma volume expansion in a female cohort, following 5-days high-intensity heat acclimation ([@B43]).

Stress Hormone Response {#S4.SS6}
-----------------------

In the present study the time to reach 38.5°C significantly increased (21.6%) from day 1 to 5 resulting in an associated increase in work (21.3%) ([Table 2](#T2){ref-type="table"}). Mean time to reach 38.5°C has been shown to be longer during STHA, using the controlled hyperthermia technique for females (51 ± 7 min), in comparison with males (48 ± 9 min) ([@B38]). Similarly, in the present study, a much larger % difference in time to 38.5°C was observed in comparison with previous studies using male cohorts with the same protocol ([@B20], [@B19], [@B21]; [@B39]). The stress hormone, cortisol, significantly increased during acclimation on day 1 but this response was not observed on day 5. Despite a greater time to 38.5°C and more work being completed, hence, indicating a heat adaptive response ([Table 4](#T4){ref-type="table"}). This agrees with previous observations on male cohorts suggesting heat acclimation reduces cortisol levels during exercise in the heat ([@B18]; [@B3]) but such findings are not universal ([@B16]; [@B53]).

Limitations and Future Directions {#S5}
=================================

In order to standardize menstrual cycle phase each female participant used a monophasic, oral contraceptive pill (OCP) but a potential limitation was that the dose of hormone concentration differed between individuals depending on their specific medication.

For future directions, information is limited on the physiological mechanisms of fluid regulation in females, following STHA. Therefore, a comparison of euhydration versus dehydration STHA, may provide a greater understanding of this area. To the authors knowledge, our earlier work ([@B21]) is the only study to have done this but with male participants.

Conclusion {#S6}
==========

In summary, this work has established the effectiveness of STHA for 5 days, using the controlled-hyperthermia technique with no fluid intake ([@B20], [@B19], [@B21]), on intermittent activity in hot environments with a female cohort, controlling for menstrual cycle phase. The current research suggests these methods of heat acclimation in a female cohort enhances thermoregulation and cardiovascular stability during intermittent exercise in the heat. These improvements may provide protection from exertional heat related illnesses associated with exercise performance. This work adds to the limited body of literature available and this is particularly important given the 2020 Olympics will be held in the hot and humid conditions of Tokyo in Japan.
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*f*~*c*~

:   cardiac frequency (b ⋅ min^--1^)

$\overset{.}{Q}$

:   cardiac output (L ⋅ min^--1^)

HST

:   heat stress test

$\overset{.}{\text{V}}\text{O}_{2\max}$

:   maximum oxygen uptake (L ⋅ min^--1^or mL ⋅ kg^--1^ ⋅ min^--1^)

MPO

:   mean power output (W)

${\overline{T}}_{b}$

:   mean body temperature (°C)

${\overline{T}}_{sk}$

:   mean skin temperature (°C)

$\overset{.}{\text{V}}\text{O}_{2}$

:   oxygen consumption (L ⋅ min^--1^ or mL ⋅ kg^--1^ ⋅ min^--1^)

$\overset{.}{\text{V}}\text{O}_{2}{peak}$

:   peak oxygen uptake (L ⋅ min^--1^or mL ⋅ kg^--1^ ⋅ min^--1^)

PPO

:   peak power output (W)

%PV

:   percentage plasma volume (%)

\[alb\]~p~

:   plasma albumin (mg ⋅ mL^--1^)

\[aldo\]~p~

:   plasma aldosterone (pg ⋅ mL^--1^)

\[cortisol\]~p~

:   plasma cortisol (ug ⋅ dl^--1^)

\[Na^+^\]~p~

:   plasma sodium (mmol ⋅ L^--1^)

TP~p~

:   plasma total protein (mg ⋅ mL^--1^)

*T*~*re*~

:   rectal temperature (°C)

RH

:   relative humidity (%)

STHA

:   short-term heat acclimation

color~u~

:   urine color (units)

osm~u~

:   urine osmolality (mOsm/kg)

SG~u~

:   urine specific gravity (units).
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